Lomofungin, an antibiotic active against fungi, yeasts, and bacteria, was found to be a potent inhibitor of purified Escherichia coli deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase. It prevents RNA synthesis by a direct interaction with the polymerase and not with the template or substrate; chain elongation is halted promptly. Three DNA-dependent RNA polymerases isolated from Saccharomyces strain 1016 were also sensitive to the antibiotic. Lomofungin does not appear to react generally with proteins, as bovine serum albumin. did not prevent the inhibitory effect and numerous other enzymes were not affected by lomofungin.
Lomofungin has a broad antibacterial and antifungal spectrum, being active against grampositive and gram-negative bacteria, yeasts, and other fungi (10) . The only published information on its mode of action was obtained by Gottlieb and Nicolas (8) , who studied its effect on Saccharomyces cerevisiae and suggested that the primary site of action is the synthesis of ribonucleic acid (RNA). In the accompanying paper (11) we showed that lomofungin markedly and rapidly inhibits RNA synthesis by yeast protoplasts. This inhibition occurs prior to any substantial reduction in protein synthesis.
To clarify the mode of action of lomofungin and determine its value as a tool for study of the role of RNA synthesis in the control of enzyme synthesis and secretion by yeast, we tested the antibiotic against isolated deoxyribonucleic acid (DNA)-dependent RNA polymerases (nucleoside triphosphate; RNA nucleotidyl transferase, EC 2.7.7.6). This communication demonstrates the inhibition by lomofungin of DNAdependent RNA polymerases from both Escherichia coli and Saccharomyces strain 1016.
MATERIALS AND METHODS Preparation of yeast cellular extract. Saccharomyces strain 1016 and the general growth conditions used are described in the accompanying paper (11) . Cells were transferred from a stock culture to 200 ml of 0.3% Difco yeast extract-0.5% Bactopeptone-0.2% glucose medium, pH 6 template, with or without antibiotic. The reaction was started by adding the partially purified RNA polymerase (2.6 yg of protein). Incubations were carried out at 37 C for the times indicated. The reaction was stopped with 1 ml of ice-cold 10% trichloroacetic acid-40 mM sodium pyrophosphate, and the radioactivity in the trichloroacetic acid-insoluble polynucleotides was measured.
Previously described methods were used for invertase (6) and for a-glucosidase (12) . Acid and alkaline phosphatases were assayed with p-nitrophenylphosphate as substrate as described by Torriani (22) and modified by Kuo and Lampen (13) . Hexokinase was determined in a coupled enzyme assay by the conversion of glucose to glucose-6-phosphate, which was measured by the reduction of nicotinamide adenine dinucleotide phosphate in the presence of glucose-6-phosphate dehydrogenase (5 
RESULTS
Effect of lomofungin on E. coli DNA-dependent RNA polymerase. Lomofungin rapidly inhibits purified E. coli DNA-dependent RNA polymerase (Table 1 ). The effect is concentration-dependent; approximately 24% inhibition occurred at 1 ,ug/ml over the time intervals indicated, and concentrations greater than 20 Ag/ml virtually eliminated enzyme activity (data not shown). The other antibiotics tested gave results in accord with their known modes of action. Rifampin inhibits bacterial RNA polymerases (9, 23) whereas a-amanitin is mainly effective in eukaryotic systems (16, 24) . Cycloheximide, which inhibits protein synthesis in eukaryotes, was without effect (14) .
Rifampin inhibits RNA synthesis by binding to the polymerase protein (9, 23), whereas antibiotics such as actinomycin D and chromomycin act by complexing with the DNA template (19, 22) . To determine which component of the enzyme system was affected by lomofungin, the drug was incubated with various concentrations of the polymerase or of DNA before the other component was added to start the reaction. Incubating the DNA and lomofungin together for 5 min before adding the polymerase did not affect the subsequent response to suboptimal levels of DNA (Fig. 1A) . In contrast, when lomofungin and increasing levels of the enzyme preparation were incubated together and the DNA was then added, no polymerase activity was subsequently detected until its level exceeded 0.65 ,ug (Fig. 1B) ; additional amounts showed essentially unimpaired activity. Thus, lomofungin at 20,ug per ml (as in Fig.   1 ) appeared to inhibit completely about 0.65 Ag of the polymerase preparation. The shape of the inhibition curve (Fig. 1B) suggests that there is a very sharp saturation to the inhibitory effect with a large degree of cooperativity, but that this is not certain in light of the fact that the antibiotic probably exists as relatively large To determine whether lomofungin prevents chain initiation or elongation, we examined the kinetics of its action on E. coli RNA polymerase (Fig. 2) . The addition of lomofungin, either at the onset of the reaction or after polynucleotide synthesis had begun, produced an immediate cessation of polynucleotide formation. Rifampin did completely prevent polynucleotide formation when added at the same time as the DNA template-but, if addition was delayed for 5 min, during which time a number of nucleotide chains had been initiated, rifampin produced only a gradual decline in activity. Thus, lomofungin definitely halts chain elongation, whereas rifampin inhibits initiation, but not elongation.
Effect of lomofungin on yeast DNA-dependent RNA polymerases. The scheme employed for isolation of the enzymes was adapted from that of Ponta et al. (18), who demonstrated their isolated polymerases to be nuclear in origin and not mitochondrial. Figure 3 shows the chromatographic separation on DEAE-cellulose of the RNA polymerases obtained from Saccharomyces strain 1016. Fractions representing the three peaks were pooled and tested for enzymatic activity in the presence of lomofungin ( Table 2) .
Each of the polymerase peaks was almost totally inhibited by lomofungin at 20 Ag per ml.
a-Amanitin inhibited both of the polymerase peaks tested (B and C), with peak C being the more sensitive. The effect of rifampin on peak A, though unexpected, was not without precedent, since one species of polymerase isolated from coconut nuclei chromatin has been reported to be inhibited by a high concentration of this drug (17) . Specificity of lomofungin. The possible inhibition of a variety of enzymes by lomofungin was tested as a criterion of its specificity for DNA-dependent RNA polymerase ( Table 3 ). The only enzyme inhibited was a-glucosidase, and full activity of this enzyme was regained after dialysis. Also, addition of bovine serum albumin at 100,ug/ml did not prevent inhibition of the E. coli RNA polymerase (results not shown). These limited observations demonstrate that lomofungin is not a general protein reactant, although it is not entirely specific for RNA polymerases. synthesis of RNA by interacting with the polymerase, but differs from that of actinomycin D which binds with the DNA template (22, 23) . Both lomofungin and rifampin completely prevented polynucleotide formation when added to the polymerase system simultaneously with the DNA template; however, only lomofungin halted chain elongation when added after polynucleotide synthesis had begun.
Lomofungin was also effective against the RNA polymerases isolated and partially purified from Saccharomyces strain 1016. Three discrete polymerase peaks were obtained, all of which were inhibited by lomofungin (20,ug/ml).
a-Amanitin inhibited peaks B and C (A not tested), and rifampin inhibited only peak A.
Polymerases A, B, and C of Ponta et al. (18) are usually termed I, II, and III, respectively, by other laboratories (see Adam, Schultz and Hall [1] ). Since we did not find a polymerase peak eluting at a concentration of ammonium sulfate greater than 0.3 M (like polymerase C of Ponta et al. [18] ) and this amanitin-insensitive enzyme is frequently not observed (1) with some contamination by polymerase from the sensitive peak C. Our rifampin-sensitive peak A is unlike polymerase IA of Adam et al. (1) , which was insensitive to rifampicin SV. This peak may well be of extranuclear origin.
Despite the uncertainties concerning the identification of the several RNA polymerase peaks obtained from Saccharomyces strain 1016, these initial studies indicate clearly the sensitivity of the enzymes to lomofungin. When viewed in conjunction with the high sensitivity of RNA synthesis in yeast cells and protoplasts (8, 11) , these results provide evidence that lomofungin is an effective inhibitor of yeast RNA polymerase both in vivo and in vitro. The antibiotic should be useful for examining the mechanisms for regulation of enzyme synthesis by yeast.
